Evidence map›Paper›PMID 18212739›Full record

ArticleOncogene2008

FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.

J B Wilson, K Yamamoto, A S Marriott, S Hussain, P Sung, M E Hoatlin, C G Mathew, M Takata, L H Thompson, G M Kupfer and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

J B WilsonMolecular Oncology and Stem Cell Research Group, School of Biological Sciences, University of Liverpool, Liverpool, UK.
K Yamamoto
A S Marriott
S Hussain
P Sung
M E Hoatlin
C G Mathew
M Takata
L H Thompson
G M Kupfer
N J Jones
University of Liverpool · GBKawasaki Medical School · JPYale University · USGuy's Hospital · GBLawrence Livermore National Laboratory · USOregon Health & Science University · USUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fanconi anemia (FA) is a human disorder characterized by cancer susceptibility and cellular sensitivity to DNA crosslinks and other damages. Thirteen complementation groups and genes are identified, including BRCA2, which is defective in the FA-D1 group. Eight of the FA proteins, including FANCG, participate in a nuclear core complex that is required for the monoubiquitylation of FANCD2 and FANCI. FANCD2, like FANCD1/BRCA2, is not part of the core complex, and we previously showed direct BRCA2-FANCD2 interaction using yeast two-hybrid analysis. We now show in human and hamster cells that expression of FANCG protein, but not the other core complex proteins, is required for co-precipitation of BRCA2 and FANCD2. We also show that phosphorylation of FANCG serine 7 is required for its co-precipitation with BRCA2, XRCC3 and FANCD2, as well as the direct interaction of BRCA2-FANCD2. These results argue that FANCG has a role independent of the FA core complex, and we propose that phosphorylation of serine 7 is the signalling event required for forming a discrete complex comprising FANCD1/BRCA2-FANCD2-FANCG-XRCC3 (D1-D2-G-X3). Cells that fail to express either phospho-Ser7-FANCG, or full length BRCA2 protein, lack the interactions amongst the four component proteins. A role for D1-D2-G-X3 in homologous recombination repair (HRR) is supported by our finding that FANCG and the RAD51-paralog XRCC3 are epistatic for sensitivity to DNA crosslinking compounds in DT40 chicken cells. Our findings further define the intricate interface between FANC and HRR proteins in maintaining chromosome stability.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsBRCA2 ProteinCell Cycle ProteinsChickensCHO CellsChromosomal InstabilityCricetinaeCricetulusDNA-Binding ProteinsFanconi Anemia Complementation Group A ProteinFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group F ProteinFanconi Anemia Complementation Group G ProteinHumansPhosphorylationAtaxia Telangiectasia Mutated ProteinsATR protein, humanBRCA2 ProteinCell Cycle ProteinsDNA-Binding ProteinsFANCA protein, humanFANCD2 protein, humanFANCF protein, humanFANCG protein, humanFanconi Anemia Complementation Group A ProteinFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group F ProteinFanconi Anemia Complementation Group G ProteinProtein Serine-Threonine KinasesSerineX-ray repair cross complementing protein 3

Identifiers

PMID18212739
OpenAlexW2038012621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.